Zevra Therapeutics, Inc. ZVRA Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s operating margin?
- Zevra Therapeutics, Inc. (ZVRA) reported operating margin of -103.9% in Q3 2025.
- How has Zevra Therapeutics, Inc.'s operating margin changed year-over-year?
- Zevra Therapeutics, Inc.'s operating margin increased by 70.7% year-over-year, from -354.2% to -103.9%.
- What is the long-term trend for Zevra Therapeutics, Inc.'s operating margin?
- Over 3 years (2020 to 2024), Zevra Therapeutics, Inc.'s operating margin has grown at a 105.9% compound annual growth rate (CAGR), from -42.2% to -368.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.